Fatigue can occur with GLP-1 medication, most often early in treatment and during dose increases
Glucagon-like refers to the fact that the structure of GLP-1 resembles that of glucagon, a hormone involved in regulating blood sugar
The functional transformation often brings people to tears when they reflect on it
Developed by Eli Lilly, retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors a mechanism that distinguishes it from approved agents such as semaglutide and tirzepatide
A lot of GLP-1s are being prescribed by untrained in obesity professionals, Levy says
For patients whose insurance wont cover GLP-1 medications, lower-cost compounded versions can seem like an attractive alternative, but the researchers urge caution